ESMO大会本周重磅开幕;超 4款国产新药出海,翰森、奥赛康、维立志博科伦 ADC新药获批上市 Insight新药周报

动脉网
Oct 19, 2025

ESMO大会本周开幕,据Insight数据库统计,10月12日至18日,全球86款创新药研发有新进展,其中1款获批上市,5款申报上市,2款首次启动III期临床,19款启动临床,26款申报临床。境外部分,本周23款药物研发有推进,包括1款首次启动III期临床,9款首次启动临床,8款首次获批临床。本周有4条新药/新适应症在海外主要国家/地区获批,如阿斯利康与安进联合宣布,美国FDA批准Tezspire...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10